OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Selection of appropriate biomarkers to monitor effectiveness of ovarian function suppression in pre-menopausal patients with ER+ breast cancer
Kelly McCann, Shari Goldfarb, Tiffany A. Traina, et al.
npj Breast Cancer (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 7
Kelly McCann, Shari Goldfarb, Tiffany A. Traina, et al.
npj Breast Cancer (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 7
Showing 7 citing articles:
Incomplete ovarian function suppression in premenopausal breast cancer patients treated with gonadotropin-releasing hormone agonists
Jinna Lin, Shuqi Zheng, Qiang Liu
Cancer Treatment Reviews (2025) Vol. 133, pp. 102879-102879
Closed Access | Times Cited: 1
Jinna Lin, Shuqi Zheng, Qiang Liu
Cancer Treatment Reviews (2025) Vol. 133, pp. 102879-102879
Closed Access | Times Cited: 1
Hormone receptor-positive early breast cancer in young women: A comprehensive review
Benjamín Walbaum, Isabel Garcia‐Fructuoso, Olga Martínez‐Sáez, et al.
Cancer Treatment Reviews (2024) Vol. 129, pp. 102804-102804
Closed Access | Times Cited: 2
Benjamín Walbaum, Isabel Garcia‐Fructuoso, Olga Martínez‐Sáez, et al.
Cancer Treatment Reviews (2024) Vol. 129, pp. 102804-102804
Closed Access | Times Cited: 2
An Overview of Long-Acting GnRH Agonists in Premenopausal Breast Cancer Patients: Survivorship Challenges and Management
Nathalie LeVasseur, Mita Manna, Katarzyna J. Jerzak
Current Oncology (2024) Vol. 31, Iss. 8, pp. 4209-4224
Open Access | Times Cited: 2
Nathalie LeVasseur, Mita Manna, Katarzyna J. Jerzak
Current Oncology (2024) Vol. 31, Iss. 8, pp. 4209-4224
Open Access | Times Cited: 2
Estrogen levels in young women with hormone receptor-positive breast cancer on ovarian function suppression therapy
Megan E. Tesch, Yue Zheng, Shoshana M. Rosenberg, et al.
npj Breast Cancer (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Megan E. Tesch, Yue Zheng, Shoshana M. Rosenberg, et al.
npj Breast Cancer (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
De novo design of a nanoregulator for the dynamic restoration of ovarian tissue in cryopreservation and transplantation
Min Jiang, Guohui Zhang, Yuan Yu, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Min Jiang, Guohui Zhang, Yuan Yu, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Clinical significance of serum estradiol monitoring in women receiving adjuvant aromatase inhibitor for hormone receptor-positive early breast cancer
Shuqin Dai, Xingping Wu, Xuefang Huang, et al.
The Breast (2024) Vol. 78, pp. 103818-103818
Open Access | Times Cited: 1
Shuqin Dai, Xingping Wu, Xuefang Huang, et al.
The Breast (2024) Vol. 78, pp. 103818-103818
Open Access | Times Cited: 1
Hormonal suppression in premenopausal patients with estrogen receptor-positive breast cancer: a randomized trial comparing monthly versus trimonthly GnRH analogs
N. Sarantis, Stefanos Zervoudis, Antigoni-Dimitra Kyritsi, et al.
Review of Clinical Pharmacology and Pharmacokinetics - International Edition (2024) Vol. 38, Iss. 3, pp. 317-326
Open Access
N. Sarantis, Stefanos Zervoudis, Antigoni-Dimitra Kyritsi, et al.
Review of Clinical Pharmacology and Pharmacokinetics - International Edition (2024) Vol. 38, Iss. 3, pp. 317-326
Open Access
